Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. Military Investigates Supplement Ingredient DMAA, Bans Sales

This article was originally published in The Tan Sheet

Executive Summary

DoD suspends DMAA sales at military stores after regulators in Canada and New Zealand restricted access and as some U.S. firms change how they market and label the ingredient. These moves and the potential for an FDA review could lead to enforcement against DMAA similar to the 2004 ban against ephedra’s use in supplements.

You may also be interested in...



Las Vegas Kratom Marketer Rolls Dice On FDA's Mandatory Recall Authority

FDA for the first time exercises its mandatory recall authority over food and supplement products to order Triangle Pharmanaturals, which opened for business in Las Vegas in April 2017, to recall all of the kratom-containing products it has distributed and to cease distributing additional products.The agency also notes in the announcement that it continues to scrutinize kratom's safety unrelated to contamination.

DoJ Enlists Supporting Cast Against ‘Bad Actors’ On Supplement Stage

DoJ explores broader action and new avenues to rid the supplement market of noncompliant firms, Deputy Assistant Attorney General Olin says at a FDLI conference. CFSAN Deputy Director Michael Roosevelt says identification of unknown supplement ingredients is a 2016 priority.

DoJ Enlists Supporting Cast Against ‘Bad Actors’ On Supplement Stage

DoJ explores broader action and new avenues to rid the supplement market of noncompliant firms, Deputy Assistant Attorney General Olin says at a FDLI conference. CFSAN Deputy Director Michael Roosevelt says identification of unknown supplement ingredients is a 2016 priority.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105495

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel